Whitman Schofield

Whitman Schofield is an experienced professional in the field of protein chemistry and preclinical biology. Currently serving as the Associate Director of Protein Chemistry at Alexion Pharmaceuticals, Inc. since September 2022, Whitman focuses on early discovery for new target identification and validation. Prior to this role, Whitman held the position of Director II of Preclinical Biology at Artizan Biosciences, Inc. from January 2017 to September 2022, following a similar role at Artizan Biosciences from April 2016 to January 2017. Whitman's academic background includes a postdoctoral position at Yale University from January 2011 to January 2017.